HIT Consultant July 31, 2024
Gav Martell, VP of Business Development & Co-founder at Yonalink

The Need to Address Accessibility Gaps

Clinical trials are a driving force of medical innovation. However, they are predominantly conducted in large urban hospitals that have larger staff and more resources, which puts trial participation out of reach for the majority of Americans who live outside of major city centers. Despite having as much interest as city-dwellers, these individuals often find participation in clinical trials nearly impossible due to daunting travel, logistical and financial challenges. Alarmingly, three out of four cancer patients eager to participate in clinical trials are thwarted by these barriers.

This lack of accessibility not only exacerbates existing healthcare disparities but also prevents underserved communities from accessing potentially life-saving treatments. The inadvertent exclusion of communities that...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Clinical Trials, Equity/SDOH, Healthcare System, Patient / Consumer, Trends
mRNA Vaccine Shows Promise In Pancreatic Cancer Trial
AI Enhances Breast Cancer Detection in Screening Trial
Can innovation in clinical trial delivery meet the demands of increasing complexity in drug development?
Podcast: How Trump’s tariffs will impact clinical trials
AI screening for heart failure clinical trial speeds up enrollment, study finds

Share This Article